These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27377813)

  • 1. The Potent Inhibitory Effect of a Naproxen-Appended Cobalt(III)-Cyclam Complex on Cancer Stem Cells.
    Cressey PB; Eskandari A; Bruno PM; Lu C; Hemann MT; Suntharalingam K
    Chembiochem; 2016 Sep; 17(18):1713-8. PubMed ID: 27377813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Stem Cell and Bulk Cancer Cell Active Copper(II) Complexes with Vanillin Schiff Base Derivatives and Naproxen.
    Lu C; Eskandari A; Cressey PB; Suntharalingam K
    Chemistry; 2017 Aug; 23(47):11366-11374. PubMed ID: 28658520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes.
    Boodram JN; Mcgregor IJ; Bruno PM; Cressey PB; Hemann MT; Suntharalingam K
    Angew Chem Int Ed Engl; 2016 Feb; 55(8):2845-50. PubMed ID: 26806362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diflunisal-adjoined cobalt(iii)-polypyridyl complexes as anti-cancer stem cell agents.
    Abe DO; Eskandari A; Suntharalingam K
    Dalton Trans; 2018 Oct; 47(39):13761-13765. PubMed ID: 30225483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex.
    Suntharalingam K; Lin W; Johnstone TC; Bruno PM; Zheng YR; Hemann MT; Lippard SJ
    J Am Chem Soc; 2014 Oct; 136(41):14413-6. PubMed ID: 25247635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of methylated cobalt-alkyne complexes with selective cytotoxicity against COX-positive cancer cell lines.
    Baecker D; Sagasser J; Karaman S; Hörmann AA; Gust R
    Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100408. PubMed ID: 34893997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cobalt(III)-Macrocyclic Scaffolds with Anti-Cancer Stem Cell Activity.
    Fang J; Gerschel P; Singh K; Apfel UP; Suntharalingam K
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Breast Cancer Stem Active Cobalt(III)-Cyclam Complex Containing Flufenamic Acid with Immunogenic Potential.
    Fang J; Orobator ON; Olelewe C; Passeri G; Singh K; Awuah SG; Suntharalingam K
    Angew Chem Int Ed Engl; 2024 Feb; 63(6):e202317940. PubMed ID: 38063406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles.
    Eskandari A; Boodram JN; Cressey PB; Lu C; Bruno PM; Hemann MT; Suntharalingam K
    Dalton Trans; 2016 Nov; 45(44):17867-17873. PubMed ID: 27774561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking.
    El-Husseiny WM; El-Sayed MA; Abdel-Aziz NI; El-Azab AS; Asiri YA; Abdel-Aziz AA
    Eur J Med Chem; 2018 Oct; 158():134-143. PubMed ID: 30216848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action.
    Ott I; Schmidt K; Kircher B; Schumacher P; Wiglenda T; Gust R
    J Med Chem; 2005 Jan; 48(2):622-9. PubMed ID: 15658875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
    Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Discrete Breast Cancer Stem Cell Mammosphere Activity of Group 10-Bis(azadiphosphine) Metal Complexes.
    Xiao Z; Johnson A; Singh K; Suntharalingam K
    Angew Chem Int Ed Engl; 2021 Mar; 60(12):6704-6709. PubMed ID: 33274606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.
    Chen Y; Wang Q; Li Z; Liu Z; Zhao Y; Zhang J; Liu M; Wang Z; Li D; Han J
    Dalton Trans; 2020 Apr; 49(16):5192-5204. PubMed ID: 32236281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects.
    Güngör T; Ozleyen A; Yılmaz YB; Siyah P; Ay M; Durdağı S; Tumer TB
    Eur J Med Chem; 2021 Oct; 221():113566. PubMed ID: 34077833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
    Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
    Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Necroptosis in Cancer Stem Cells using a Nickel(II)-Dithiocarbamate Phenanthroline Complex.
    Flamme M; Cressey PB; Lu C; Bruno PM; Eskandari A; Hemann MT; Hogarth G; Suntharalingam K
    Chemistry; 2017 Jul; 23(40):9674-9682. PubMed ID: 28556445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cytotoxic activity and genotoxicity of structurally well characterized potent cobalt(II) phen-based antitumor drug entities: An in vitro and in vivo approach.
    Khan HY; Ansari MO; Shadab GGHA; Tabassum S; Arjmand F
    Bioorg Chem; 2019 Jul; 88():102963. PubMed ID: 31071506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenic Cell Death of Breast Cancer Stem Cells Induced by an Endoplasmic Reticulum-Targeting Copper(II) Complex.
    Kaur P; Johnson A; Northcote-Smith J; Lu C; Suntharalingam K
    Chembiochem; 2020 Dec; 21(24):3618-3624. PubMed ID: 32776422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2, 3-Diaryl-5-ethylsulfanylmethyltetrahydrofurans as a new class of COX-2 inhibitors and cytotoxic agents.
    Singh P; Mittal A; Kaur S; Holzer W; Kumar S
    Org Biomol Chem; 2008 Aug; 6(15):2706-12. PubMed ID: 18633528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.